• 1. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 2. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399
• 3. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 4. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 5. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Hydroxypyridines

Professional Introduction to Compound with CAS No. 736088-02-1 and Product Name: 6-(Hydroxymethyl)pyridine-3,4-diol

6-(Hydroxymethyl)pyridine-3,4-diol, identified by the Chemical Abstracts Service Number (CAS No.) 736088-02-1, is a significant compound in the field of pharmaceutical chemistry and bioorganic synthesis. This heterocyclic diol derivative has garnered attention due to its unique structural properties and potential applications in medicinal chemistry. The compound's pyridine core, functionalized with hydroxymethyl groups at the 3 and 4 positions, makes it a versatile intermediate for the synthesis of more complex molecules, particularly in the development of novel therapeutic agents.

The chemical structure of 6-(Hydroxymethyl)pyridine-3,4-diol consists of a six-membered aromatic ring containing nitrogen, which is a key feature contributing to its reactivity and biological activity. The presence of two hydroxymethyl (-CH?OH) groups introduces both hydrophilic and lipophilic characteristics, allowing the compound to interact effectively with biological targets. This balance between polar and non-polar regions is particularly valuable in drug design, as it can enhance solubility and membrane permeability, critical factors for oral bioavailability and cellular uptake.

Recent advancements in computational chemistry have enabled a deeper understanding of the interactions between 6-(Hydroxymethyl)pyridine-3,4-diol and biological macromolecules. Molecular docking studies have revealed that this compound can bind to various enzymes and receptors with high affinity. For instance, research has shown that derivatives of this scaffold exhibit inhibitory activity against enzymes involved in inflammatory pathways, such as cyclooxygenase (COX) and lipoxygenase (LOX). These findings align with the growing interest in developing anti-inflammatory agents that target multiple pathways simultaneously.

In addition to its potential as an anti-inflammatory agent, 6-(Hydroxymethyl)pyridine-3,4-diol has shown promise in the development of antimicrobial compounds. The pyridine ring serves as a scaffold for designing molecules that disrupt bacterial cell wall synthesis or interfere with essential metabolic processes. Preliminary experiments have demonstrated that certain analogs of this compound exhibit broad-spectrum antibacterial activity against Gram-positive and Gram-negative strains. This is particularly relevant in the context of rising antibiotic resistance, where novel antimicrobial strategies are urgently needed.

The synthesis of 6-(Hydroxymethyl)pyridine-3,4-diol involves multi-step organic reactions that highlight its synthetic utility. One common synthetic route involves the condensation of formaldehyde with 3,4-dimethylpyridine under basic conditions, followed by oxidation to introduce the hydroxyl groups. This method leverages readily available starting materials and established reaction protocols, making it suitable for large-scale production. Advances in green chemistry have also been applied to optimize these reactions, reducing waste and improving yields through catalytic methods or solvent-free conditions.

The pharmacological profile of 6-(Hydroxymethyl)pyridine-3,4-diol has been further explored through in vitro and in vivo studies. Animal models have been used to assess its toxicity profile and pharmacokinetic properties. Preliminary results indicate that the compound is well-tolerated at moderate doses but may exhibit mild hepatotoxicity at higher concentrations. These findings are crucial for guiding future clinical trials and ensuring safe dosing regimens if the compound moves into human therapeutic use.

The versatility of 6-(Hydroxymethyl)pyridine-3,4-diol as a building block has also been recognized in material science applications beyond pharmaceuticals. Its ability to form hydrogen bonds due to the hydroxyl groups allows it to be incorporated into polymers and coatings that require enhanced adhesion or water resistance. Recent research has demonstrated its use in creating biodegradable polymers for medical implants or smart materials that respond to environmental stimuli. These applications underscore the broad utility of this compound across multiple scientific disciplines.

Future directions for research on 6-(Hydroxymethyl)pyridine-3,4-diol include exploring its role in neurodegenerative diseases. The pyridine scaffold is known to interact with neurological targets such as acetylcholinesterase and monoamine oxidases, which are implicated in conditions like Alzheimer's disease. By modifying the substituents on the pyridine ring or introducing additional functional groups, researchers aim to develop more potent and selective neuroprotective agents based on this scaffold.

In conclusion,6-(Hydroxymethyl)pyridine-3,4-diol (CAS No. 736088-02-1) represents a promising compound with diverse applications in pharmaceuticals and material science. Its unique structural features enable interactions with biological targets relevant to inflammation, antimicrobial infections, and potentially neurodegenerative diseases. The synthetic accessibility of this compound further enhances its appeal for both academic research and industrial development. As our understanding of its properties continues to grow,6-(Hydroxymethyl)pyridine-3,4-diol is poised to play a significant role in advancing therapeutic strategies across multiple domains.

• 40222-77-3(6-(Hydroxymethyl)pyridin-3-ol)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)